Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site revision tag v3.4.2 and removed older notices about government funding and operating status (revision v3.4.1); these are administrative updates and do not change the trial details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with a reference for updates. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedUI and metadata labels were updated. The additions include 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; the items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was expanded to include many new sites across the US, Canada, and internationally, and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.